SkyView Investment Advisors’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-71,773
| Closed | -$728K | – | 888 |
|
|
2023
Q1 | $728K | Hold |
71,773
| – | – | 0.17% | 162 |
|
|
2022
Q4 | $717K | Hold |
71,773
| – | – | 0.22% | 160 |
|
|
2022
Q3 | $719K | Hold |
71,773
| – | – | 0.21% | 163 |
|
|
2022
Q2 | $710K | Hold |
71,773
| – | – | 0.19% | 179 |
|
|
2022
Q1 | $706K | Hold |
71,773
| – | – | 0.17% | 183 |
|
|
2021
Q4 | $701K | Buy |
71,773
+5,310
| +8% | +$51.9K | 0.16% | 167 |
|
|
2021
Q3 | $650K | Buy |
+66,463
| New | +$650K | 0.18% | 144 |
|